Vogel, ChristianChristianVogelRox, KatharinaKatharinaRoxWagenlehner, FlorianFlorianWagenlehnerTitz, AlexanderAlexanderTitz2025-11-132025-11-132024https://jlupub.ub.uni-giessen.de/handle/jlupub/20975https://doi.org/10.22029/jlupub-20324Bacteria develop biofilms for protection and persistent colonization. Biofilms of pathogenic bacteria can lead to serious medical problems. Bacterial biofilms on catheters used in the treatment of urinary tract diseases represent a major challenge for antibiotic therapy. Several attempts to eradicate biofilms using classical antibiotics and various alternatives, including antibiotic treatment of surfaces, surfaces that release silver ions, and surfaces with anti-adhesive properties, have not shown clinical efficacy in biofilm prevention or removal. Pseudomonas aeruginosa is one of the most problematic biofilm-forming uropathogens and accounts for approximately 10% of urinary tract infections. Novel glycomimetics that inhibit bacterial lectins have shown promising results in the prevention of P. aeruginosa biofilms and in interference with bacterial virulence. This mini-review summarizes the status of glycomimetic development and provides a perspective on their use in clinical practice.enNamensnennung 4.0 Internationalddc:610